From Department of Surgical Sciences, Uppsala University, Sweden (A.W., M.B., S.S.); Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden (R.H.); Department of Surgery and Department of Clinical Science and Education, Karolinska Institutet at Södersjukhuset, Stockholm, Sweden (A.L.); Department of Vascular Diseases, Skåne University Hospital, Malmö, Sweden (J.H., A.G.); Department of Vascular Surgery, Sahlgrenska University Hospital, University of Gothenburg, Sweden (K.S., M.L.); and Department of Surgery, Falun County Hospital, Falun, Sweden (S.S.).
Circulation. 2016 Oct 18;134(16):1141-1148. doi: 10.1161/CIRCULATIONAHA.116.022305. Epub 2016 Sep 14.
A general abdominal aortic aneurysm (AAA) screening program, targeting 65-year-old men, has gradually been introduced in Sweden since 2006 and reached nationwide coverage in 2015. The aim of this study was to determine the outcome of this program.
Data on the number of invited and examined men, screening-detected AAAs, AAAs operated on, and surgical outcome were retrieved from all 21 Swedish counties for the years 2006 through 2014. AAA-specific mortality data were retrieved from the Swedish Cause of Death Registry. A linear regression analysis was used to estimate the effect on AAA-specific mortality among all men ≥65 years of age for the observed time period. The long-term effects were projected by using a validated Markov model.
Of 302 957 men aged 65 years invited, 84% attended. The prevalence of screening-detected AAA was 1.5%. After a mean of 4.5 years, 29% of patients with AAA had been operated on, with a 30-day mortality rate of 0.9% (1.3% after open repair and 0.3% after endovascular repair, P<0.001). The introduction of screening was associated with a significant reduction in AAA-specific mortality (mean, 4.0% per year of screening, P=0.020). The number needed to screen and the number needed to operate on to prevent 1 premature death were 667 and 1.5, respectively. With a total population of 9.5 million, the Swedish national AAA-screening program was predicted to annually prevent 90 premature deaths from AAA and to gain 577 quality-adjusted life-years. The incremental cost-efficiency ratio was estimated to be €7770 per quality-adjusted life-years.
Screening 65-year-old men for AAA is an effective preventive health measure and is highly cost-effective in a contemporary setting. These findings confirm the results from earlier randomized controlled trials and model studies in a large population-based setting of the importance for future healthcare decision making.
自 2006 年以来,瑞典逐渐推出了一项针对 65 岁男性的普通腹主动脉瘤(AAA)筛查计划,并于 2015 年实现了全国覆盖。本研究旨在确定该计划的结果。
从 2006 年至 2014 年,从瑞典的 21 个县检索了邀请和检查男性人数、筛查发现的 AAA、接受手术治疗的 AAA 以及手术结果的数据。从瑞典死因登记处检索了 AAA 特异性死亡率数据。使用线性回归分析来估计观察期间所有≥65 岁男性的 AAA 特异性死亡率的影响。使用经过验证的马尔可夫模型预测长期影响。
在 302957 名 65 岁的男性中,84%的人接受了邀请。筛查发现 AAA 的患病率为 1.5%。平均随访 4.5 年后,29%的 AAA 患者接受了手术治疗,30 天死亡率为 0.9%(开放修复为 1.3%,血管内修复为 0.3%,P<0.001)。筛查的引入与 AAA 特异性死亡率的显著降低相关(每年筛查降低 4.0%,P=0.020)。预防 1 例过早死亡需要筛查的人数和需要手术的人数分别为 667 和 1.5。在 950 万总人口中,瑞典国家 AAA 筛查计划预计每年可预防 90 例 AAA 导致的过早死亡,并获得 577 个质量调整生命年。增量成本效益比估计为每质量调整生命年 7770 欧元。
对 65 岁男性进行 AAA 筛查是一种有效的预防保健措施,在当前环境下具有很高的成本效益。这些发现证实了早期随机对照试验和模型研究的结果,即大规模人群中 AAA 筛查对未来医疗保健决策的重要性。